Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature

被引:19
|
作者
Mori, Yoshiyuki [1 ]
Ogasawara, Toru [1 ]
Motoi, Toru [2 ]
Shimizu, Yuichiro [3 ]
Chikazu, Daichi [1 ]
Tamura, Kazumi [1 ]
Fukumoto, Seiji [3 ]
Takato, Tsuyoshi [1 ]
机构
[1] Tokyo Univ Hosp, Dept Oral Maxillofacial Surg Dent & Orthodont, Tokyo 1138655, Japan
[2] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 173, Japan
[3] Tokyo Univ Hosp, Div Nephrol & Endocrinol, Dept Med, Tokyo 1138655, Japan
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2010年 / 109卷 / 03期
关键词
ONCOGENIC OSTEOMALACIA; FGF23;
D O I
10.1016/j.tripleo.2009.10.052
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Tumor-induced osteomalacia (TIO) is a rare acquired paraneoplastic disease characterized by renal phosphate wasting and hypophosphatemia. Recently, it was reported that tumors associated with TIO produce fibroblast growth factor (FGF) 23, identified as the last member of the FGF family and of which excessive action causes several hypophosphatemic diseases whereas deficient FGF23 activity results in hyperphosphatemic tumoral calcinosis. In this case, although it was difficult to locate the associated tumor, an abnormal mass in the left maxilla was detected by imaging. The tumor was removed by partial resection of the left maxillary alveolar region. Thereafter, serum level of FGF23 rapidly decreased, hypophosphatemia improved, and the clinical symptoms greatly improved. Histopathologic diagnosis of the tumor was phosphaturic mesenchymal tumor, mixed connective tissue variant. Immunohistochemical findings confirmed that the removed tumor produced FGF23. These results indicate that development of osteomalacia in this patient was related to the maxillary tumor, which overexpressed FGF23. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: e57-e63)
引用
收藏
页码:E57 / E63
页数:7
相关论文
共 50 条
  • [42] Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt
    Seemann, LaRae
    Padala, Sandeep Anand
    Mohammed, Azeem
    Belayneh, Nardos
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2019, 7
  • [43] Tumor-induced osteomalacia combined with acromegaly: A case report
    Li, Xiang
    Ni, Xiaolin
    Chai, Xiaofeng
    Wang, Linjie
    Jiang, Yan
    Jing, Hongli
    Huo, Li
    Wu, Huanwen
    Yao, Yong
    Jin, Jin
    Feng, Bin
    Xia, Yu
    Yu, Wei
    Chi, Yue
    Liu, Wei
    Pang, Qianqian
    Cui, Lijia
    Jiajue, Ruizhi
    Gong, Yiyi
    Wang, Ou
    Li, Mei
    Xing, Xiaoping
    Xia, Weibo
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1517 (01) : 88 - 92
  • [44] Osteomalacia associated with a fibroblast growth factor-23 secreting chest wall tumor
    Paul, Subroto
    Kurtz, Michael
    Mentzer, Steven J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 134 (03): : 803 - 805
  • [45] Tumor-induced Osteomalacia: A Comprehensive Review
    Minisola, Salvatore
    Fukumoto, Seiji
    Xia, Weibo
    Corsi, Alessandro
    Colangelo, Luciano
    Scillitani, Alfredo
    Pepe, Jessica
    Cipriani, Cristiana
    Thakker, Rajesh, V
    ENDOCRINE REVIEWS, 2023, 44 (02) : 323 - 353
  • [46] Unusual presentation of tumor-induced osteomalacia mismanaged due to misdiagnosis: A literature review based on a case report
    Fatollahzadeh, Mahdieh
    Meybodi, Hamid Reza Aghaei
    Pajavand, Hamid
    Payab, Moloud
    Ebrahimpur, Mahbube
    Ebrahimi, Pouya
    CLINICAL CASE REPORTS, 2024, 12 (05):
  • [47] A Challenging Case of Tumor-Induced Osteomalacia
    Paccou, Julien
    Pflimlin, Arnaud
    Glowacki, Francois
    Cortet, Bernard
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (01): : E60 - E61
  • [48] Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23
    Bansal, Shweta
    Khazim, Khaled
    Suri, Rajeev
    Martin, DeAndra
    Werner, Sherry
    Fanti, Paolo
    CLINICAL NEPHROLOGY, 2016, 85 (01) : 57 - 68
  • [49] SPECT/CT with 99mTc-Tektrotyd in imaging tumors secreting fibroblast growth factor 23 (tumor-induced osteomalacia)
    Slashchuk, K.
    Degtyarev, M.
    Rumyantsev, P.
    Serzhenko, S.
    Baranova, O.
    Trukhin, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S99 - S100
  • [50] Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease
    Hu, Fangke
    Jiang, Chengying
    Zhang, Qiang
    Shi, Huaiyin
    Wei, Lixin
    Wang, Yan
    DISEASE MARKERS, 2016, 2016